Plasma metabolomics and scar pathogenesis: Insights from Mendelian randomization analysis

Area of Science:

• Biochemistry
• Genetics
• Dermatology

Background:

• Scar formation after tissue injury is a significant clinical problem.
• Metabolic processes and inflammation are key factors in scar development and fibrotic outcomes.

Purpose of the Study:

• To investigate causal links between plasma metabolites and scar pathogenesis.
• Utilize Mendelian randomization (MR) to explore these metabolic relationships.

Main Methods:

• Employed a two-sample MR approach using genome-wide association study (GWAS) data.
• Analyzed metabolite levels from 8,299 individuals and scar outcomes from 463,010 European skin samples.
• Applied five MR methods and sensitivity analyses for robust causal inference and to address pleiotropy.

Main Results:

• Identified four plasma metabolites significantly associated with scar risk.
• (S)-α-amino-ω-caprolactam, N-acetylalanine, and glycochenodeoxycholate 3-sulfate correlated with increased scarring.
• Alliin showed a protective effect against scar formation, with consistent results across methods.

Conclusions:

• Established causal relationships between specific metabolites and scar formation.
• Metabolic modulation presents potential therapeutic strategies for managing scar development.
• Findings open new avenues for targeting metabolic pathways in scar treatment.